New antibody aims to dissolve lung clots with less bleeding risk
Disease control
Ongoing
This study tests a new drug called TS23, a monoclonal antibody designed to help break down blood clots in the lungs. It is for people with intermediate-risk pulmonary embolism, a serious condition where clots block blood flow. The trial compares different doses of TS23 against a …
Phase: PHASE2 • Sponsor: Translational Sciences, Inc. • Aim: Disease control
Last updated Jul 02, 2026 08:00 UTC